| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 503.386 | 532.583 | 522.309 | 460.476 | 461.377 | 550.329 | 659.267 | 734.223 | 733.300 | 765.356 |
| Total Income - EUR | 508.396 | 537.508 | 527.212 | 464.792 | 463.690 | 550.587 | 659.288 | 734.285 | 733.637 | 767.230 |
| Total Expenses - EUR | 456.075 | 459.931 | 466.978 | 426.904 | 434.801 | 509.718 | 610.539 | 690.661 | 712.033 | 737.689 |
| Gross Profit/Loss - EUR | 52.321 | 77.576 | 60.234 | 37.888 | 28.889 | 40.869 | 48.749 | 43.624 | 21.604 | 29.541 |
| Net Profit/Loss - EUR | 43.777 | 63.926 | 50.542 | 33.306 | 24.248 | 35.990 | 42.785 | 36.313 | 16.144 | 25.941 |
| Employees | 6 | 7 | 6 | 7 | 8 | 7 | 7 | 7 | 8 | 7 |
Check the financial reports for the company - Farmacia Hypocrate S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.164 | 809 | 528 | 395 | 990 | 774 | 563 | 861 | 683 | 506 |
| Current Assets | 162.957 | 170.484 | 147.847 | 169.442 | 151.210 | 182.972 | 186.400 | 203.707 | 235.554 | 213.607 |
| Inventories | 74.284 | 78.983 | 83.812 | 74.233 | 75.306 | 73.314 | 62.284 | 68.189 | 78.249 | 112.683 |
| Receivables | 55.562 | 24.943 | 60.458 | 72.044 | 51.175 | 90.931 | 103.816 | 129.938 | 92.162 | 76.249 |
| Cash | 33.111 | 66.558 | 3.577 | 23.165 | 24.729 | 18.728 | 20.299 | 5.581 | 65.143 | 24.676 |
| Shareholders Funds | 43.822 | 63.970 | 50.586 | 33.349 | 24.290 | 36.031 | 42.826 | 36.354 | 16.185 | 25.981 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 120.299 | 107.324 | 97.789 | 136.488 | 127.910 | 147.765 | 144.137 | 168.339 | 220.126 | 188.321 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Hypocrate S.r.l.